来自MSN13 天
Eosinophilic Asthma
Eosinophilic asthma (also known as e-asthma or eos asthma) is a severe form of asthma that causes high levels of eosinophils in the lung tissue, blood, and mucus. Eosinophils are a type of immune ...
A high eosinophil level, for example, can indicate a range of several health conditions, from allergic reactions and asthma ...
Discovery of a novel form of cell death in eosinophils, white blood cells linked to triggering asthma, could lead to a new treatment for the disease, says respiratory physician Wen Li, director of ...
Mepolizumab is efficacious in patients with specific phenotypes of severe asthma characterized by persistent, glucocorticosteroid-resistant eosinophilia. Reslizumab may also prove to be ...
Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and presents some key findings from recent patient research conducted in Europe ...
呼吸系统疾病始终是全球公共健康的焦点问题之一。随着医学的不断进步,呼吸系统疾病的防治面临着新的挑战和机遇。今年9月,慢阻肺正式被纳入国家基本公共卫生服务项目,意味着患者将获得更广泛的支持与管理。同时,哮喘治疗也进入了全新时代,生物制剂的应用正在为重度 ...
Amali Samarasinghe, PhD, associate professor in the Department of Pediatrics at UT Health Science Center, describes herself as an aficionada of the alternative hypothesis. “I have a passion to uncover ...
More information: Risk of developing eosinophilic esophagitis with preexisting asthma, allergic rhinitis, atopic dermatitis, or food allergy, American College of Allergy, Asthma and Immunology ...
A new study published in the journal of Clinical and Experimental Allergy showed that the combination of allergen ...
New indication supported by the MANDARA trial, which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroidsAstraZeneca’s Fasenra (benralizumab) ...
Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...
The results announced today from the fifth cohort of the RESOLVE trial, for treatment of EoE, are derived from 12, 4 mg injections of EP-104GI (total dose of 48 mg) administered to the lower ...